BMI and outcomes in patients with metastatic kidney cancer treated with first-line TKIs
This study looked at whether high or low body mass [...]
This study looked at whether high or low body mass [...]
Papillary renal cell carcinoma (pRCC) is the second most common [...]
In a presentation at the 19th Meeting of the European Association [...]
This year there was some very important data presented at [...]
Previous studies have shown that cancer patients who experience immune-related [...]
A recent study published in JAMA Network Open looked at [...]
Most studies have shown that many cancer patients are at [...]
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
XP11.2 translation renal cell carcinoma (RCC) is a very rare [...]
There is a lot of ongoing research to understand the [...]